PMID- 10894360 OWN - NLM STAT- MEDLINE DCOM- 20001120 LR - 20111117 IS - 1525-8165 (Print) IS - 1525-8165 (Linking) VI - 9 IP - 3 DP - 2000 Jun TI - Upregulation of interleukin-10 and inhibition of alloantigen responses by transferrin and transferrin-derived glycans. PG - 381-92 AB - Previous studies have shown that critically timed administration of transferrin (Tf) facilitates induction of immunologic unresponsiveness. Here, we determined in mixed leukocyte culture (MLC) and in concanavalin A (ConA)-driven cultures the effect of exogenous Tf and Tf-derived glycans (Tf-Gly) on lymphocyte proliferation. In cultures of human blood lymphocytes, Tf inhibited selectively alloantigen-driven proliferation in MLC, but not ConA-stimulated lymphocyte proliferation. Deglycosylation of Tf abrogated the inhibitory effect of Tf on alloantigen-induced lymphocyte proliferation, and, consistent with a role for glycans, an effect qualitatively and quantitatively similar to Tf was exerted by purified Tf-Gly. Glycans isolated from other proteins, for example, immunoglobulin G (IgG) or fibrinogen, failed to inhibit alloantigen-induced proliferation selectively. Rather, they suppressed lymphocyte proliferation in a non-specific manner. Determination of cytokines in MLC supernatant showed a downregulation of interleukin-1beta (IL-1beta), tumor necrosis factor-alpha (TNF-alpha), IL-2, and IL-12 (p40), along with an upregulation of IL-10, a pattern entirely consistent with the observed effects of Tf and Tf-Gly on alloantigen-induced lymphocyte proliferation. The effect of Tf on MLC was directly IL-10-dependent. IL-10 levels were inversely correlated with lymphocyte proliferation and CD86 expression. Neutralization of IL-10 by anti-IL-10 monoclonal antibody (mAb) blocked the effect of Tf. The MLC-modulating effect of Tf (or Tf-Gly) was not dependent upon the Tf receptor CD71 but appeared to be mediated by a Gly-responsive receptor. These data suggest a role of Tf, and, in particular, Tf-Gly, in allo-interactions that is independent from the role of Tf in iron metabolism, and appears to involve co-stimulatory signals. FAU - Lesnikova, M AU - Lesnikova M AD - Fred Hutchinson Cancer Research Center and University of Washington, Seattle 98109-1024, USA. FAU - Lesnikov, V AU - Lesnikov V FAU - Arrighi, S AU - Arrighi S FAU - Kistler, G AU - Kistler G FAU - Pierpaoli, W AU - Pierpaoli W FAU - Deeg, H J AU - Deeg HJ LA - eng GR - HL36444/HL/NHLBI NIH HHS/United States PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - J Hematother Stem Cell Res JT - Journal of hematotherapy & stem cell research JID - 100892915 RN - 0 (Antibodies, Monoclonal) RN - 0 (Antigens, CD) RN - 0 (Antigens, Differentiation, B-Lymphocyte) RN - 0 (CD71 antigen) RN - 0 (Cytokines) RN - 0 (Immunoglobulin G) RN - 0 (Isoantigens) RN - 0 (Polysaccharides) RN - 0 (Receptors, Transferrin) RN - 0 (Transferrin) RN - 11028-71-0 (Concanavalin A) RN - 130068-27-8 (Interleukin-10) SB - IM MH - Antibodies, Monoclonal/pharmacology MH - Antigens, CD/immunology/pharmacology MH - Antigens, Differentiation, B-Lymphocyte/immunology/pharmacology MH - Concanavalin A/pharmacology MH - Cytokines/biosynthesis/drug effects MH - Humans MH - Immunoglobulin G/pharmacology MH - Interleukin-10/genetics/immunology/*physiology MH - Isoantigens/*drug effects/immunology MH - Lymphocyte Activation/drug effects MH - Lymphocyte Culture Test, Mixed MH - Polysaccharides/*pharmacology MH - Receptors, Transferrin MH - Transferrin/analogs & derivatives/*pharmacology MH - Up-Regulation/*drug effects EDAT- 2000/07/14 11:00 MHDA- 2001/02/28 10:01 CRDT- 2000/07/14 11:00 PHST- 2000/07/14 11:00 [pubmed] PHST- 2001/02/28 10:01 [medline] PHST- 2000/07/14 11:00 [entrez] AID - 10.1089/15258160050079498 [doi] PST - ppublish SO - J Hematother Stem Cell Res. 2000 Jun;9(3):381-92. doi: 10.1089/15258160050079498.